RTP801 is a critical factor in the neurodegeneration process of A53T α-synuclein in a mouse model of Parkinson's disease under chronic restraint stress-Reference-Cited by-同舟云学术

RTP801 is a critical factor in the neurodegeneration process of A53T α-synuclein in a mouse model of Parkinson's disease under chronic restraint stress

Published:2018-01-17 Issue:4 Volume:175 Page:590-605
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Zhang Zhao¹^ORCID,Chu Shi-Feng¹,Wang Sha-Sha²¹,Jiang Yi-Na³,Gao Yan¹,Yang Peng-Fei¹,Ai Qi-Di³,Chen Nai-Hong¹³⁴²^ORCID

Affiliation:

1. State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

2. School of Basic Medicine; Shanxi University of Traditional Chinese Medicine; Shanxi China

3. College of Pharmacy; Hunan University of Chinese Medicine; Changsha China

4. Institute of Clinical Pharmacology; Guangzhou University of Chinese Medicine; Guangzhou China

Funder

Fundamental Research Funds for the Central Universities

PUMC Youth Fund

Scientific Research Foundation of the Higher Education Institutions of Hunan Province

Key Research and Development Project of Hunan Province

Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study

Natural Science Foundation of Beijing Municipality

CAMS Innovation Fund for Medical Sciences (CIFMS)

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14091/fullpdf

Reference53 articles.

1. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system;Ahima;Neuroscience,1990

2. Type II corticosteroid receptor-like immunoreactivity in the rat cerebellar cortex: differential regulation by corticosterone;Ahima;Neuroendocrinology,1992

3. The Concise Guide To PHARMACOLOGY 2017/18: Enzymes;Alexander;Br J Pharmacol,2015a

4. The Concise Guide to PHARMACOLOGY 2017/18: Transporters;Alexander;Br J Pharmacol,2015b

5. Alterations of T-lymphocyte populations in Parkinson disease;Baba;Parkinsonism Relat Disord,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rg1 ameliorates stress-exacerbated Parkinson’s disease in mice by eliminating RTP801 and α-synuclein autophagic degradation obstacle;Acta Pharmacologica Sinica;2024-09-03

2. Correction to “RTP801 is a critical factor in the neurodegeneration process of A53T a‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress”;British Journal of Pharmacology;2024-08-29

3. A recent update on drugs and alternative approaches for parkinsonism;Neuropeptides;2024-04

4. The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s disease;Neural Regeneration Research;2024-01-31

5. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease;Biomolecules;2024-01-05